Share Price and Basic Stock Data
Last Updated: July 3, 2025, 11:41 am
| PEG Ratio | 6.90 |
|---|
Competitors of Colgate-Palmolive (India) Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Honasa Consumer Ltd | 9,628 Cr. | 296 | 547/190 | 150 | 36.9 | 0.00 % | 7.44 % | 5.51 % | 10.0 |
| Ambica Agarbathies Aroma & Industries Ltd | 49.1 Cr. | 28.6 | 37.0/24.0 | 32.9 | 63.6 | 0.00 % | 8.09 % | 1.42 % | 10.0 |
| Ador Multi Products Ltd | 44.0 Cr. | 94.2 | 108/23.4 | 19.4 | 0.00 % | 12.8 % | 5.48 % | 10.0 | |
| Kaya Ltd | 576 Cr. | 440 | 702/204 | 106 | 0.00 % | 2.82 % | % | 10.0 | |
| Jyothy Labs Ltd | 12,511 Cr. | 341 | 596/268 | 33.5 | 55.8 | 1.02 % | 25.1 % | 19.4 % | 1.00 |
| Industry Average | 70,719.14 Cr | 2,114.81 | 55.63 | 107.49 | 0.79% | 30.20% | 24.58% | 4.94 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,301 | 1,197 | 1,387 | 1,291 | 1,351 | 1,324 | 1,471 | 1,396 | 1,490 | 1,497 | 1,619 | 1,462 | 1,463 |
| Expenses | 872 | 871 | 979 | 930 | 899 | 906 | 989 | 927 | 958 | 988 | 1,122 | 1,007 | 964 |
| Operating Profit | 429 | 326 | 408 | 361 | 452 | 418 | 482 | 468 | 532 | 508 | 497 | 454 | 498 |
| OPM % | 33% | 27% | 29% | 28% | 33% | 32% | 33% | 34% | 36% | 34% | 31% | 31% | 34% |
| Other Income | 9 | 2 | 11 | 10 | 18 | -5 | 21 | 18 | 23 | 23 | 76 | 20 | 19 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 44 | 44 | 44 | 44 | 43 | 44 | 44 | 41 | 42 | 42 | 42 | 41 | 38 |
| Profit before tax | 393 | 282 | 374 | 327 | 426 | 369 | 458 | 443 | 511 | 489 | 530 | 433 | 478 |
| Tax % | 18% | 26% | 26% | 26% | 26% | 26% | 26% | 26% | 26% | 26% | 26% | 25% | 26% |
| Net Profit | 324 | 210 | 278 | 243 | 316 | 274 | 340 | 330 | 380 | 364 | 395 | 323 | 355 |
| EPS in Rs | 11.90 | 7.71 | 10.22 | 8.94 | 11.63 | 10.06 | 12.50 | 12.14 | 13.96 | 13.38 | 14.52 | 11.87 | 13.05 |
Last Updated: May 31, 2025, 10:01 am
Below is a detailed analysis of the quarterly data for Colgate-Palmolive (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 1,463.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,462.00 Cr. (Dec 2024) to 1,463.00 Cr., marking an increase of 1.00 Cr..
- For Expenses, as of Mar 2025, the value is 964.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,007.00 Cr. (Dec 2024) to 964.00 Cr., marking a decrease of 43.00 Cr..
- For Operating Profit, as of Mar 2025, the value is 498.00 Cr.. The value appears strong and on an upward trend. It has increased from 454.00 Cr. (Dec 2024) to 498.00 Cr., marking an increase of 44.00 Cr..
- For OPM %, as of Mar 2025, the value is 34.00%. The value appears strong and on an upward trend. It has increased from 31.00% (Dec 2024) to 34.00%, marking an increase of 3.00%.
- For Other Income, as of Mar 2025, the value is 19.00 Cr.. The value appears to be declining and may need further review. It has decreased from 20.00 Cr. (Dec 2024) to 19.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 1.00 Cr..
- For Depreciation, as of Mar 2025, the value is 38.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 41.00 Cr. (Dec 2024) to 38.00 Cr., marking a decrease of 3.00 Cr..
- For Profit before tax, as of Mar 2025, the value is 478.00 Cr.. The value appears strong and on an upward trend. It has increased from 433.00 Cr. (Dec 2024) to 478.00 Cr., marking an increase of 45.00 Cr..
- For Tax %, as of Mar 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Dec 2024) to 26.00%, marking an increase of 1.00%.
- For Net Profit, as of Mar 2025, the value is 355.00 Cr.. The value appears strong and on an upward trend. It has increased from 323.00 Cr. (Dec 2024) to 355.00 Cr., marking an increase of 32.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is 13.05. The value appears strong and on an upward trend. It has increased from 11.87 (Dec 2024) to 13.05, marking an increase of 1.18.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 10:53 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,579 | 3,982 | 3,868 | 3,982 | 4,188 | 4,462 | 4,525 | 4,841 | 5,100 | 5,226 | 5,680 | 6,040 |
| Expenses | 2,915 | 3,159 | 2,929 | 3,038 | 3,074 | 3,226 | 3,323 | 3,331 | 3,534 | 3,679 | 3,779 | 4,082 |
| Operating Profit | 664 | 823 | 940 | 944 | 1,114 | 1,236 | 1,202 | 1,510 | 1,566 | 1,547 | 1,901 | 1,958 |
| OPM % | 19% | 21% | 24% | 24% | 27% | 28% | 27% | 31% | 31% | 30% | 33% | 32% |
| Other Income | 115 | 32 | 7 | 41 | 26 | 68 | 49 | 30 | 26 | 42 | 57 | 139 |
| Interest | 0 | 0 | 0 | 0 | 0 | 2 | 10 | 7 | 6 | 5 | 5 | 4 |
| Depreciation | 51 | 75 | 111 | 133 | 157 | 159 | 198 | 182 | 177 | 175 | 172 | 163 |
| Profit before tax | 728 | 780 | 835 | 851 | 983 | 1,143 | 1,043 | 1,350 | 1,409 | 1,410 | 1,781 | 1,930 |
| Tax % | 26% | 28% | 30% | 32% | 32% | 32% | 22% | 23% | 23% | 26% | 26% | 26% |
| Net Profit | 540 | 559 | 581 | 577 | 673 | 776 | 816 | 1,035 | 1,078 | 1,047 | 1,324 | 1,437 |
| EPS in Rs | 19.85 | 20.55 | 21.37 | 21.23 | 24.76 | 28.52 | 30.02 | 38.07 | 39.65 | 38.50 | 48.67 | 52.83 |
| Dividend Payout % | 68% | 58% | 47% | 47% | 97% | 81% | 93% | 100% | 101% | 101% | 119% | 97% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 3.52% | 3.94% | -0.69% | 16.64% | 15.30% | 5.15% | 26.84% | 4.15% | -2.88% | 26.46% | 8.53% |
| Change in YoY Net Profit Growth (%) | 0.00% | 0.42% | -4.62% | 17.33% | -1.33% | -10.15% | 21.68% | -22.68% | -7.03% | 29.33% | -17.92% |
Colgate-Palmolive (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 6% |
| 3 Years: | 6% |
| TTM: | 6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 12% |
| 3 Years: | 10% |
| TTM: | 7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 12% |
| 3 Years: | 17% |
| 1 Year: | -15% |
| Return on Equity | |
|---|---|
| 10 Years: | 64% |
| 5 Years: | 73% |
| 3 Years: | 72% |
| Last Year: | 81% |
Last Updated: Unknown
Balance Sheet
Last Updated: June 16, 2025, 12:36 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 14 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| Reserves | 586 | 757 | 1,004 | 1,247 | 1,497 | 1,420 | 1,567 | 1,139 | 1,707 | 1,689 | 1,847 | 1,637 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 83 | 102 | 91 | 83 | 69 | 72 | 61 |
| Other Liabilities | 894 | 932 | 972 | 1,037 | 1,039 | 1,097 | 908 | 1,637 | 1,084 | 1,098 | 1,250 | 1,293 |
| Total Liabilities | 1,493 | 1,702 | 2,003 | 2,311 | 2,564 | 2,626 | 2,604 | 2,894 | 2,902 | 2,883 | 3,197 | 3,019 |
| Fixed Assets | 556 | 782 | 1,008 | 1,108 | 1,146 | 1,191 | 1,123 | 1,065 | 963 | 862 | 794 | 776 |
| CWIP | 142 | 141 | 78 | 167 | 159 | 199 | 190 | 145 | 122 | 114 | 110 | 38 |
| Investments | 37 | 37 | 31 | 31 | 31 | 31 | 19 | 19 | 0 | 0 | 0 | 0 |
| Other Assets | 759 | 742 | 885 | 1,005 | 1,228 | 1,206 | 1,272 | 1,666 | 1,817 | 1,907 | 2,292 | 2,204 |
| Total Assets | 1,493 | 1,702 | 2,003 | 2,311 | 2,564 | 2,626 | 2,604 | 2,894 | 2,902 | 2,883 | 3,197 | 3,019 |
Below is a detailed analysis of the balance sheet data for Colgate-Palmolive (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 27.00 Cr..
- For Reserves, as of Mar 2025, the value is 1,637.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,847.00 Cr. (Mar 2024) to 1,637.00 Cr., marking a decrease of 210.00 Cr..
- For Borrowings, as of Mar 2025, the value is 61.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 72.00 Cr. (Mar 2024) to 61.00 Cr., marking a decrease of 11.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 1,293.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,250.00 Cr. (Mar 2024) to 1,293.00 Cr., marking an increase of 43.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 3,019.00 Cr.. The value appears to be improving (decreasing). It has decreased from 3,197.00 Cr. (Mar 2024) to 3,019.00 Cr., marking a decrease of 178.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 776.00 Cr.. The value appears to be declining and may need further review. It has decreased from 794.00 Cr. (Mar 2024) to 776.00 Cr., marking a decrease of 18.00 Cr..
- For CWIP, as of Mar 2025, the value is 38.00 Cr.. The value appears to be declining and may need further review. It has decreased from 110.00 Cr. (Mar 2024) to 38.00 Cr., marking a decrease of 72.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 2,204.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,292.00 Cr. (Mar 2024) to 2,204.00 Cr., marking a decrease of 88.00 Cr..
- For Total Assets, as of Mar 2025, the value is 3,019.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,197.00 Cr. (Mar 2024) to 3,019.00 Cr., marking a decrease of 178.00 Cr..
Notably, the Reserves (1,637.00 Cr.) exceed the Borrowings (61.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 664.00 | 823.00 | 940.00 | 944.00 | 1.00 | -82.00 | -101.00 | -90.00 | -82.00 | -68.00 | -71.00 | -60.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 9 | 6 | 6 | 10 | 12 | 18 | 17 | 11 | 9 | 16 | 11 | 11 |
| Inventory Days | 54 | 59 | 63 | 72 | 72 | 56 | 58 | 69 | 79 | 78 | 68 | 63 |
| Days Payable | 136 | 130 | 128 | 136 | 148 | 152 | 144 | 142 | 179 | 169 | 155 | 187 |
| Cash Conversion Cycle | -73 | -65 | -59 | -55 | -63 | -79 | -68 | -63 | -91 | -75 | -76 | -113 |
| Working Capital Days | -49 | -47 | -40 | -43 | -39 | -33 | -36 | -21 | -83 | -24 | -31 | -45 |
| ROCE % | 144% | 122% | 114% | 96% | 74% | 71% | 73% | 65% | 92% | 92% | 79% | 97% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Multi Cap Fund | 500,473 | 0.49 | 135.65 | 500,473 | 2025-04-22 17:25:44 | 0% |
| Nippon India Large Cap Fund | 497,594 | 0.55 | 134.87 | 497,594 | 2025-04-22 13:03:42 | 0% |
| Franklin India Prima Fund | 450,000 | 1.21 | 121.97 | 450,000 | 2025-04-22 17:25:44 | 0% |
| NJ Balanced Advantage Fund | 345,381 | 2.36 | 93.61 | 345,381 | 2025-04-22 17:25:44 | 0% |
| Nippon India ETF Nifty Next 50 Junior BeES | 341,321 | 1.98 | 92.51 | 341,321 | 2025-04-22 17:25:44 | 0% |
| NJ Flexi Cap Fund | 187,246 | 4.68 | 50.75 | 187,246 | 2025-04-22 17:25:44 | 0% |
| Franklin India Equity Advantage Fund | 169,458 | 1.46 | 45.93 | 169,458 | 2025-04-22 17:25:44 | 0% |
| Axis Growth Opportunities Fund | 123,167 | 0.28 | 33.38 | 123,167 | 2025-04-22 17:25:44 | 0% |
| Baroda BNP Paribas Midcap Fund | 105,000 | 1.59 | 28.46 | 105,000 | 2025-04-22 17:25:44 | 0% |
| Templeton India Equity Income Fund | 100,000 | 1.31 | 27.1 | 100,000 | 2025-04-22 17:25:44 | 0% |
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 48.67 | 38.50 | 39.65 | 38.07 | 30.02 |
| Diluted EPS (Rs.) | 48.67 | 38.50 | 39.65 | 38.07 | 30.02 |
| Cash EPS (Rs.) | 54.97 | 44.93 | 46.16 | 44.78 | 37.30 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 68.91 | 63.11 | 63.78 | 42.86 | 58.61 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 68.91 | 63.11 | 63.78 | 42.86 | 58.61 |
| Dividend / Share (Rs.) | 58.00 | 39.00 | 40.00 | 38.00 | 28.00 |
| Revenue From Operations / Share (Rs.) | 208.85 | 192.15 | 187.50 | 178.00 | 166.37 |
| PBDIT / Share (Rs.) | 72.70 | 58.85 | 58.54 | 56.62 | 45.99 |
| PBIT / Share (Rs.) | 66.39 | 52.42 | 52.02 | 49.91 | 38.71 |
| PBT / Share (Rs.) | 65.49 | 51.83 | 51.80 | 49.64 | 38.36 |
| Net Profit / Share (Rs.) | 48.67 | 38.50 | 39.65 | 38.07 | 30.02 |
| PBDIT Margin (%) | 34.80 | 30.62 | 31.22 | 31.80 | 27.64 |
| PBIT Margin (%) | 31.79 | 27.28 | 27.74 | 28.04 | 23.26 |
| PBT Margin (%) | 31.35 | 26.97 | 27.62 | 27.89 | 23.05 |
| Net Profit Margin (%) | 23.30 | 20.03 | 21.14 | 21.38 | 18.04 |
| Return on Networth / Equity (%) | 70.61 | 61.00 | 62.16 | 88.80 | 51.21 |
| Return on Capital Employeed (%) | 92.26 | 79.28 | 77.76 | 106.38 | 60.73 |
| Return On Assets (%) | 41.40 | 36.32 | 37.15 | 35.77 | 31.35 |
| Asset Turnover Ratio (%) | 1.87 | 1.81 | 1.76 | 1.76 | 1.73 |
| Current Ratio (X) | 1.54 | 1.43 | 1.37 | 0.84 | 1.16 |
| Quick Ratio (X) | 1.30 | 1.12 | 1.04 | 0.64 | 0.82 |
| Inventory Turnover Ratio (X) | 4.61 | 4.31 | 3.95 | 3.95 | 4.95 |
| Dividend Payout Ratio (NP) (%) | 88.35 | 101.29 | 47.92 | 141.85 | 66.62 |
| Dividend Payout Ratio (CP) (%) | 78.22 | 86.80 | 41.15 | 120.59 | 53.62 |
| Earning Retention Ratio (%) | 11.65 | -1.29 | 52.08 | -41.85 | 33.38 |
| Cash Earning Retention Ratio (%) | 21.78 | 13.20 | 58.85 | -20.59 | 46.38 |
| Interest Coverage Ratio (X) | 395.76 | 325.74 | 270.10 | 212.15 | 130.09 |
| Interest Coverage Ratio (Post Tax) (X) | 269.83 | 216.38 | 183.92 | 143.63 | 85.91 |
| Enterprise Value (Cr.) | 72358.90 | 40063.94 | 41171.93 | 41551.30 | 33657.22 |
| EV / Net Operating Revenue (X) | 12.74 | 7.67 | 8.07 | 8.58 | 7.44 |
| EV / EBITDA (X) | 36.59 | 25.03 | 25.86 | 26.98 | 26.91 |
| MarketCap / Net Operating Revenue (X) | 12.98 | 7.84 | 8.22 | 8.76 | 7.53 |
| Retention Ratios (%) | 11.64 | -1.29 | 52.07 | -41.85 | 33.37 |
| Price / BV (X) | 39.34 | 23.88 | 24.17 | 36.38 | 21.38 |
| Price / Net Operating Revenue (X) | 12.98 | 7.84 | 8.22 | 8.76 | 7.53 |
| EarningsYield | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 |
After reviewing the key financial ratios for Colgate-Palmolive (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 48.67. This value is within the healthy range. It has increased from 38.50 (Mar 23) to 48.67, marking an increase of 10.17.
- For Diluted EPS (Rs.), as of Mar 24, the value is 48.67. This value is within the healthy range. It has increased from 38.50 (Mar 23) to 48.67, marking an increase of 10.17.
- For Cash EPS (Rs.), as of Mar 24, the value is 54.97. This value is within the healthy range. It has increased from 44.93 (Mar 23) to 54.97, marking an increase of 10.04.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 68.91. It has increased from 63.11 (Mar 23) to 68.91, marking an increase of 5.80.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 68.91. It has increased from 63.11 (Mar 23) to 68.91, marking an increase of 5.80.
- For Dividend / Share (Rs.), as of Mar 24, the value is 58.00. This value exceeds the healthy maximum of 3. It has increased from 39.00 (Mar 23) to 58.00, marking an increase of 19.00.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 208.85. It has increased from 192.15 (Mar 23) to 208.85, marking an increase of 16.70.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 72.70. This value is within the healthy range. It has increased from 58.85 (Mar 23) to 72.70, marking an increase of 13.85.
- For PBIT / Share (Rs.), as of Mar 24, the value is 66.39. This value is within the healthy range. It has increased from 52.42 (Mar 23) to 66.39, marking an increase of 13.97.
- For PBT / Share (Rs.), as of Mar 24, the value is 65.49. This value is within the healthy range. It has increased from 51.83 (Mar 23) to 65.49, marking an increase of 13.66.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 48.67. This value is within the healthy range. It has increased from 38.50 (Mar 23) to 48.67, marking an increase of 10.17.
- For PBDIT Margin (%), as of Mar 24, the value is 34.80. This value is within the healthy range. It has increased from 30.62 (Mar 23) to 34.80, marking an increase of 4.18.
- For PBIT Margin (%), as of Mar 24, the value is 31.79. This value exceeds the healthy maximum of 20. It has increased from 27.28 (Mar 23) to 31.79, marking an increase of 4.51.
- For PBT Margin (%), as of Mar 24, the value is 31.35. This value is within the healthy range. It has increased from 26.97 (Mar 23) to 31.35, marking an increase of 4.38.
- For Net Profit Margin (%), as of Mar 24, the value is 23.30. This value exceeds the healthy maximum of 10. It has increased from 20.03 (Mar 23) to 23.30, marking an increase of 3.27.
- For Return on Networth / Equity (%), as of Mar 24, the value is 70.61. This value is within the healthy range. It has increased from 61.00 (Mar 23) to 70.61, marking an increase of 9.61.
- For Return on Capital Employeed (%), as of Mar 24, the value is 92.26. This value is within the healthy range. It has increased from 79.28 (Mar 23) to 92.26, marking an increase of 12.98.
- For Return On Assets (%), as of Mar 24, the value is 41.40. This value is within the healthy range. It has increased from 36.32 (Mar 23) to 41.40, marking an increase of 5.08.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 1.87. It has increased from 1.81 (Mar 23) to 1.87, marking an increase of 0.06.
- For Current Ratio (X), as of Mar 24, the value is 1.54. This value is within the healthy range. It has increased from 1.43 (Mar 23) to 1.54, marking an increase of 0.11.
- For Quick Ratio (X), as of Mar 24, the value is 1.30. This value is within the healthy range. It has increased from 1.12 (Mar 23) to 1.30, marking an increase of 0.18.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 4.61. This value is within the healthy range. It has increased from 4.31 (Mar 23) to 4.61, marking an increase of 0.30.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 88.35. This value exceeds the healthy maximum of 50. It has decreased from 101.29 (Mar 23) to 88.35, marking a decrease of 12.94.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 78.22. This value exceeds the healthy maximum of 50. It has decreased from 86.80 (Mar 23) to 78.22, marking a decrease of 8.58.
- For Earning Retention Ratio (%), as of Mar 24, the value is 11.65. This value is below the healthy minimum of 40. It has increased from -1.29 (Mar 23) to 11.65, marking an increase of 12.94.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 21.78. This value is below the healthy minimum of 40. It has increased from 13.20 (Mar 23) to 21.78, marking an increase of 8.58.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 395.76. This value is within the healthy range. It has increased from 325.74 (Mar 23) to 395.76, marking an increase of 70.02.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 269.83. This value is within the healthy range. It has increased from 216.38 (Mar 23) to 269.83, marking an increase of 53.45.
- For Enterprise Value (Cr.), as of Mar 24, the value is 72,358.90. It has increased from 40,063.94 (Mar 23) to 72,358.90, marking an increase of 32,294.96.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 12.74. This value exceeds the healthy maximum of 3. It has increased from 7.67 (Mar 23) to 12.74, marking an increase of 5.07.
- For EV / EBITDA (X), as of Mar 24, the value is 36.59. This value exceeds the healthy maximum of 15. It has increased from 25.03 (Mar 23) to 36.59, marking an increase of 11.56.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 12.98. This value exceeds the healthy maximum of 3. It has increased from 7.84 (Mar 23) to 12.98, marking an increase of 5.14.
- For Retention Ratios (%), as of Mar 24, the value is 11.64. This value is below the healthy minimum of 30. It has increased from -1.29 (Mar 23) to 11.64, marking an increase of 12.93.
- For Price / BV (X), as of Mar 24, the value is 39.34. This value exceeds the healthy maximum of 3. It has increased from 23.88 (Mar 23) to 39.34, marking an increase of 15.46.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 12.98. This value exceeds the healthy maximum of 3. It has increased from 7.84 (Mar 23) to 12.98, marking an increase of 5.14.
- For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 23) to 0.01, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Colgate-Palmolive (India) Ltd:
- Net Profit Margin: 23.3%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 92.26% (Industry Average ROCE: 30.2%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 70.61% (Industry Average ROE: 24.58%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 269.83
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.3
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 46.7 (Industry average Stock P/E: 55.63)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 23.3%
About the Company - Qualitative Analysis
Colgate-Palmolive (India) Ltd. is a Public Limited Listed company incorporated on 23/09/1937 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24200MH1937PLC002700 and registration number is 002700. Currently Company is involved in the business activities of Manufacture of other chemical products. Company's Total Operating Revenue is Rs. 6040.17 Cr. and Equity Capital is Rs. 27.20 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Personal Care | Colgate Research Centre, Main Street, Mumbai Maharashtra 400076 | investors_grievance@colpal.com http://www.colgatepalmolive.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mukul Deoras | Chairman |
| Ms. Prabha Narasimhan | Managing Director & CEO |
| Mr. M S Jacob | WholeTime Director & CFO |
| Mr. Surender Sharma | Whole Time Director |
| Mr. Sekhar Natarajan | Ind. Non-Executive Director |
| Ms. Sukanya Kripalu | Ind. Non-Executive Director |
| Ms. Gopika Pant | Ind. Non-Executive Director |
| Dr. Indu Bhushan | Ind. Non-Executive Director |
| Mr. Sanjay Gupta | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Colgate-Palmolive (India) Ltd?
Colgate-Palmolive (India) Ltd's intrinsic value (as of 04 July 2025) is 1895.39 — 23.05% lower the current market price of 2,463.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 66,989 Cr. market cap, FY2025-2026 high/low of 3,893/2,312, reserves of 1,637 Cr, and liabilities of 3,019 Cr.
What is the Market Cap of Colgate-Palmolive (India) Ltd?
The Market Cap of Colgate-Palmolive (India) Ltd is 66,989 Cr..
What is the current Stock Price of Colgate-Palmolive (India) Ltd as on 04 July 2025?
The current stock price of Colgate-Palmolive (India) Ltd as on 04 July 2025 is 2,463.
What is the High / Low of Colgate-Palmolive (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Colgate-Palmolive (India) Ltd stocks is ₹3,893/2,312.
What is the Stock P/E of Colgate-Palmolive (India) Ltd?
The Stock P/E of Colgate-Palmolive (India) Ltd is 46.7.
What is the Book Value of Colgate-Palmolive (India) Ltd?
The Book Value of Colgate-Palmolive (India) Ltd is 61.2.
What is the Dividend Yield of Colgate-Palmolive (India) Ltd?
The Dividend Yield of Colgate-Palmolive (India) Ltd is 2.09 %.
What is the ROCE of Colgate-Palmolive (India) Ltd?
The ROCE of Colgate-Palmolive (India) Ltd is 105 %.
What is the ROE of Colgate-Palmolive (India) Ltd?
The ROE of Colgate-Palmolive (India) Ltd is 81.2 %.
What is the Face Value of Colgate-Palmolive (India) Ltd?
The Face Value of Colgate-Palmolive (India) Ltd is 1.00.